DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF

Nuria Gutierrez-Prat; Hedwig L Zuberer; Luca Mangano; Zahra Karimaddini; Luise Wolf; Stefka Tyanova; Lisa C Wellinger; Daniel Marbach; Vera Griesser; Piergiorgio Pettazzoni; James R Bischoff; Daniel Rohle; Chiara Palladino; Igor Vivanco

doi:10.26508/lsa.202101235

Research Article

Open Access

DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF

View ORCID ProfileNuria Gutierrez-Prat, View ORCID ProfileHedwig L Zuberer, View ORCID ProfileLuca Mangano, View ORCID ProfileZahra Karimaddini, View ORCID ProfileLuise Wolf, View ORCID ProfileStefka Tyanova, View ORCID ProfileLisa C Wellinger, View ORCID ProfileDaniel Marbach, Vera Griesser, View ORCID ProfilePiergiorgio Pettazzoni, James R Bischoff, View ORCID ProfileDaniel Rohle, View ORCID ProfileChiara Palladino, View ORCID ProfileIgor Vivanco

Nuria Gutierrez-Prat

1Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Nuria Gutierrez-Prat

Hedwig L Zuberer

1Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Hedwig L Zuberer

Luca Mangano

1Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Luca Mangano

Zahra Karimaddini

2Roche Pharma Research and Early Development, Informatics, Roche Innovation Center Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Zahra Karimaddini

Luise Wolf

2Roche Pharma Research and Early Development, Informatics, Roche Innovation Center Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Luise Wolf

Stefka Tyanova

2Roche Pharma Research and Early Development, Informatics, Roche Innovation Center Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Stefka Tyanova

Lisa C Wellinger

4Ridgeline Discovery Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Lisa C Wellinger

Daniel Marbach

3Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Daniel Marbach

Vera Griesser

3Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Piergiorgio Pettazzoni

1Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Piergiorgio Pettazzoni

James R Bischoff

1Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel Rohle

4Ridgeline Discovery Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Daniel Rohle

Chiara Palladino

1Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Chiara Palladino

Igor Vivanco

5Institute of Pharmaceutical Science, King’s College London, London, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Igor Vivanco

Published 17 May 2022. DOI: 10.26508/lsa.202101235

Article
Figures & Data
Info
Metrics
Reviewer Comments
PDF

Statistics from Altmetric.com

Article usage

Article usage: May 2022 to June 2022

	Abstract	Full	Pdf
May 2022	45	684	328
Jun 2022	9	207	116

PreviousNext

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF

Message Subject (Your Name) has sent you a message from Life Science Alliance

Message Body (Your Name) thought you would like to see the Life Science Alliance web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

DUSP4 restricts MAPK overdose in melanoma

Nuria Gutierrez-Prat, Hedwig L Zuberer, Luca Mangano, Zahra Karimaddini, Luise Wolf, Stefka Tyanova, Lisa C Wellinger, Daniel Marbach, Vera Griesser, Piergiorgio Pettazzoni, James R Bischoff, Daniel Rohle, Chiara Palladino, Igor Vivanco

Life Science Alliance May 2022, 5 (9) e202101235; DOI: 10.26508/lsa.202101235